Condition
Recurrent Stroke
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06404242Recruiting
Plaque Characteristics Predict Recurrent Stroke in MCA Stroke Patients
NCT05907694Not ApplicableRecruiting
Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure
NCT07174414Phase 3Not Yet Recruiting
Cilostazol for Prevention of Recurrent Stroke Trial
Showing all 3 trials